Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2014 May;64(622):e275-81.
doi: 10.3399/bjgp14X679705.

Improving anticoagulation in atrial fibrillation: observational study in three primary care trusts

John Robson  1 , Isabel Dostal, Rohini Mathur, Ratna Sohanpal, Sally Hull, Sotiris Antoniou, Peter Maccallum, Richard Schilling, Luis Ayerbe, Kambiz Boomla
Affiliations
Observational Study

Improving anticoagulation in atrial fibrillation: observational study in three primary care trusts

John Robson et al. Br J Gen Pract. 2014 May.

Abstract

Background: Atrial fibrillation (AF) is a cause of stroke, and undertreatment with anticoagulants is a persistent issue despite their effectiveness.

Aim: To increase the proportion of people with AF treated appropriately using anticoagulants, and reduce inappropriate antiplatelet therapy.

Design of study: Cross-sectional analysis.

Setting: Electronic patient health records on 4604 patients with AF obtained from general practices in three inner London primary care trusts between April 2011 and 2013.

Method: The Anticoagulant Programme East London (APEL) sought to achieve its aims through an intervention with three components: altering professional beliefs using new clinical guidance and related education; facilitating change using computer software to support clinical decisions and patient review optimising anticoagulation; motivating change through evaluative feedback showing individual practice performance relative to peers.

Results: From April 2011 to April 2013, the proportion of people with CHA2DS2-VASc ≥1 on anticoagulants increased from 52.6% to 59.8% (trend difference P<0.001). The proportion of people with CHA2DS2-VASc ≥1 on aspirin declined from 37.7% to 30.3% (trend difference P<0.001). Comparing the 2 years before the intervention with the 2 years after, numbers of new people on the AF register almost doubled from 108 to 204.

Conclusions: The APEL programme supports improvement in clinical managing AF by a combined programme of education around agreed guidance, computer aids to facilitate decision-making and patient review and feedback of locally identifiable results. If replicated nationally over 3 years, such a programme could result in approximately 1600 fewer strokes every year.

Keywords: anticoagulants; atrial fibrillation; clinical decision support systems; patterns; prescribing; primary health care; stroke.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Anticoagulant and antiplatelet use in patients with AF with CHAD2S2-VASC ≥1.
Figure 2.
Figure 2.
Funnel plot: proportion on anticoagulants by east London practices.
See this image and copyright information in PMC

References

    1. Heeringa J, van der Kuip DA, Hofman A, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J. 2006;27(8):949–953. - PubMed
    1. Mathur R, Pollara E, Hull S, et al. Ethnicity and stroke risk in patients with atrial fibrillation. Heart. 2013;99:1087–1092. - PubMed
    1. QStroke 2013. Risk calculator: http://qstroke.org (accessed 6 Mar 2014).
    1. QRisk2 2013. Risk calculator: http://qrisk.org (accessed 6 Mar 2014).
    1. Camm AJ, Lip YHG, De Caterina R, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with with the special contribution of the European Heart Rhythm Association. Eur Heart J. 2012;33(21):2719–2747. - PubMed

Publication types

MeSH terms

Substances